资讯

CDC virus expert resigns after RFK Jr.’s purge of vaccine advisers
Fiona Havers, who oversees CDC respiratory virus data, told colleagues she no longer had confidence the data would be used ...
hMPV is likely one of the viruses making us sick this winter. Here’s what to know about ...
MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.
FDA expands approval of Moderna's RSV vaccine to some adults under age 60
The FDA expanded its approval of Moderna's RSV vaccine on Thursday to include adults under age 60 at increased risk of the ...
STAT4 天
FDA clears Moderna’s RSV vaccine for use in people aged 18 to 59
The FDA expanded the approval of Moderna’s RSV vaccine, extending the license to include more adults and giving the company a ...
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at ...
Expanded indication builds on existing U.S. FDA approval of mRESVIA for adults aged 60 and older CAMBRIDGE, MA / ACCESS ...
The Manhattan Mercury4 天
New Antibody Shot Could Help Protect Babies From RSV
THURSDAY, June 12, 2025 (HealthDay News) — A newly approved shot could soon help protect babies from respiratory syncytial ...
FDA clears Moderna’s RSV vaccine for use in people ages 18 to 59
The Food and Drug Administration expanded the approval of Moderna’s RSV vaccine on Thursday, extending the license to include ...
BioPharma Dive3 天
Moderna wins FDA OK to widen use of RSV vaccine
The agency’s decision to clear Moderna’s shot for use in certain younger adults is a much-needed win for a company that’s ...
Global Respiratory Syncytial Virus Treatment Market Size To Reach USD 8,332.5 Million By ...
The global respiratory syncytial virus respiratory syncytial virus treatment market is undergoing rapid growth, driven by rising vaccine uptake, impr ...